APA

Drent M. L., Tollefsen A. T. M., van Heusden F. H. J. A., Hoenderdos E. B. M., Jonker J. J. C. & van der Veen E. A. (20030129). Dose-dependent efficacy of miglitol, an alpha-glucosidase inhibitor, in type 2 diabetic patients on diet alone: results of a 24-week double-blind placebo-controlled study. : Diabetes, nutrition & metabolism.

Chicago

Drent M L, Tollefsen A T M, van Heusden F H J A, Hoenderdos E B M, Jonker J J C and van der Veen E A. 20030129. Dose-dependent efficacy of miglitol, an alpha-glucosidase inhibitor, in type 2 diabetic patients on diet alone: results of a 24-week double-blind placebo-controlled study. : Diabetes, nutrition & metabolism.

Harvard

Drent M. L., Tollefsen A. T. M., van Heusden F. H. J. A., Hoenderdos E. B. M., Jonker J. J. C. and van der Veen E. A. (20030129). Dose-dependent efficacy of miglitol, an alpha-glucosidase inhibitor, in type 2 diabetic patients on diet alone: results of a 24-week double-blind placebo-controlled study. : Diabetes, nutrition & metabolism.

MLA

Drent M L, Tollefsen A T M, van Heusden F H J A, Hoenderdos E B M, Jonker J J C and van der Veen E A. Dose-dependent efficacy of miglitol, an alpha-glucosidase inhibitor, in type 2 diabetic patients on diet alone: results of a 24-week double-blind placebo-controlled study. : Diabetes, nutrition & metabolism. 20030129.